These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vivo evaluation of a novel electrically conductive polypyrrole/poly(D,L-lactide) composite and polypyrrole-coated poly(D,L-lactide-co-glycolide) membranes. Wang Z; Roberge C; Dao LH; Wan Y; Shi G; Rouabhia M; Guidoin R; Zhang Z J Biomed Mater Res A; 2004 Jul; 70(1):28-38. PubMed ID: 15174106 [TBL] [Abstract][Full Text] [Related]
5. Effect of GDNF-releasing biodegradable microspheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts. Clavreul A; Sindji L; Aubert-Pouëssel A; Benoît JP; Menei P; Montero-Menei CN Eur J Pharm Biopharm; 2006 Jun; 63(2):221-8. PubMed ID: 16497494 [TBL] [Abstract][Full Text] [Related]
6. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study. Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053 [TBL] [Abstract][Full Text] [Related]
7. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Liu J; Meisner D; Kwong E; Wu XY; Johnston MR Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581 [TBL] [Abstract][Full Text] [Related]
8. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Díez S; Tros de Ilarduya C Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172 [TBL] [Abstract][Full Text] [Related]
9. The brain tissue response to biodegradable poly(methylidene malonate 2.1.2)-based microspheres in the rat. Fournier E; Passirani C; Colin N; Sagodira S; Menei P; Benoit JP; Montero-Menei CN Biomaterials; 2006 Oct; 27(28):4963-74. PubMed ID: 16759690 [TBL] [Abstract][Full Text] [Related]
10. Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. Menei P; Daniel V; Montero-Menei C; Brouillard M; Pouplard-Barthelaix A; Benoit JP Biomaterials; 1993 May; 14(6):470-8. PubMed ID: 8507795 [TBL] [Abstract][Full Text] [Related]
11. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies. Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213 [TBL] [Abstract][Full Text] [Related]
12. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain. Khan A; Sommer W; Fuxe K; Akhtar S J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659 [TBL] [Abstract][Full Text] [Related]
15. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres. Smeets R; Gerhards F; Stein JM; Paz RM; Vogt S; Pautke C; Weitz J; Kolk A J Biomed Mater Res A; 2011 Jan; 96(1):177-85. PubMed ID: 21105166 [TBL] [Abstract][Full Text] [Related]
16. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles. Zhao A; Rodgers VG J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186 [TBL] [Abstract][Full Text] [Related]
17. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen. Gavini E; Sanna V; Juliano C; Giunchedi P J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374 [TBL] [Abstract][Full Text] [Related]
18. Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats. McRae A; Ling EA; Hjorth S; Dahlström A; Mason D; Tice T Mol Neurobiol; 1994; 9(1-3):191-205. PubMed ID: 7888096 [TBL] [Abstract][Full Text] [Related]
19. Scanning electron microscopic study of cell attachment to biodegradable polymer implants. Zislis T; Mark DE; Cerbas EL; Hollinger JO J Oral Implantol; 1989; 15(3):160-7. PubMed ID: 2561760 [TBL] [Abstract][Full Text] [Related]
20. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination. Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]